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Nerita Versicolor carboxypeptidase inhibitor (NvCI) is the strongest inhibitor reported so far for the 
M14A subfamily of carboxypeptidases. It comprises 53 residues and a protein fold composed of a two-
stranded antiparallel β sheet connected by three loops and stabilized by three disulfide bridges. Here 
we report the oxidative folding and reductive unfolding pathways of NvCI. Much debate has gone on 
whether protein conformational folding guides disulfide bond formation or instead they are disulfide 
bonds that favour the arrangement of local or global structural elements. We show here that for NvCI 
both possibilities apply. Under physiological conditions, this protein folds trough a funnelled pathway 
involving a network of kinetically connected native-like intermediates, all sharing the disulfide bond 
connecting the two β-strands. In contrast, under denaturing conditions, the folding of NvCI is under 
thermodynamic control and follows a “trial and error” mechanism, in which an initial quasi-stochastic 
population of intermediates rearrange their disulfide bonds to attain the stable native topology. Despite 
their striking mechanistic differences, the efficiency of both folding routes is similar. The present study 
illustrates thus a surprising plasticity in the folding of this extremely stable small disulfide-rich inhibitor 
and provides the basis for its redesign for biomedical applications.
Deciphering how a string of amino acid residues folds into a biologically active three-dimensional structure 
remains a major challenge in structural biology1–7. Much effort has gone into identifying the productive interme-
diates that are assumed to be necessary for rapid protein folding4, 5, 8–10. However, folding intermediates are usually 
difficult to isolate and characterize due to their short half-life and highly flexible structures.
The formation of disulfide bonds adds an additional layer of complexity to the folding pathway of many pro-
teins. The term ‘oxidative folding’ describes the composite process by which a reduced, unfolded protein gains 
both its native disulfide bonds (disulfide-bond formation) and its native structure (conformational folding)11, 12. 
Disulfide bonds display unique chemical and structural characteristics that allow them to be used as probes to 
monitor the progression of protein folding/unfolding pathways and of the structural properties of the interme-
diates11, 13. Indeed, the landmark discovery that the information to fold a protein is fully contained in the pri-
mary amino acid sequence was based on oxidative folding experiments with RNase A, a protein containing four 
disulfide bonds14.
Oxidative folding is a very complex process, where an interplay between conformational folding, disulfide 
bond formation and disulfide isomerization takes place15, 16. The relationship between these three reactions is not 
trivial, since oxidation, reduction and reshuffling rates are modulated by the effective concentration of thiolate 
anions as well as by the reactivity, proximity and accessibility of both free cysteines and disulfide bonds, which, 
in turn, depend on their relative burial in the intermediate conformations during folding11, 12, 16–18. The formation 
of native disulfide bonds can promote and accelerate the arrangement of local or global secondary and tertiary 
structure elements or, conversely, strong structural propensities might force the preferential formation of native 
1Institut de Biotecnologia i de Biomedicina and Departament de Bioquímica i de Biologia Molecular, Universitat 
Autònoma de Barcelona, 08193, Bellaterra, (Barcelona), Spain. 2Servei de Proteòmica i Biologia Estructural, 
Universitat Autònoma de Barcelona, Barcelona, Spain. 3Instituto Multidisciplinario de Biología Celular (IMBICE) – 
CONICET, La Plata, Argentina. Correspondence and requests for materials should be addressed to F.X.A. (email: 
FrancescXavier.Aviles@uab.cat) or S.V. (email: salvador.ventura@uab.es)
Received: 9 February 2017
Accepted: 1 June 2017
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 7: 5457  | DOI:10.1038/s41598-017-05657-7
disulfide bonds12. Indeed, whether disulfide bond formation drives protein folding or vice versa, has remained a 
major unsolved problem in protein folding, despite its chemical and biophysical relevance19.
The analysis of oxidative folding reactions, pioneered by Creighton20, is based in the slow kinetics and par-
ticular chemistry of disulfide bond formation. By using an appropriate thiol quenching reaction, such as alkyl-
ation or acidification, disulfide bond formation can be stopped and disulfide intermediates can be isolated. This 
approach has been applied for the elucidation of the folding pathways of more than 30 different disulfide-rich 
proteins (reviewed in refs 21–23). To date, these studies have revealed a great diversity of folding pathways that 
differ mainly in the heterogeneity and native disulfide-bond content of the intermediates that accumulate along 
the course of oxidative folding. Two extreme opposite models of oxidative folding are exemplified by bovine 
pancreatic trypsin inhibitor (BPTI) and hirudin. The BPTI-like model is characterized by the predominance of 
a limited number of intermediates that adopt native disulfide bonds and native-like substructures24. Conversely, 
the hirudin-like model is defined by a highly heterogeneous population of intermediates containing mostly 
non-native disulfides, including the presence of scrambled isomers (fully oxidized species that contain at least 
two non-native disulfide bonds)25. Both BPTI and hirudin are protease inhibitors. Proteins displaying this activity 
usually comprise small folds cross-linked by several disulfides and accordingly have been among the most valua-
ble models to dissect oxidative folding reactions (reviewed in ref. 26).
Metallocarboxypeptidases (MCPs) are zinc-dependent enzymes that hydrolyse the C-terminal residue(s) of 
peptides and proteins. Their activity is tightly regulated and normally takes place outside of the cell. Mammals 
contain several types of MCPs that are involved in a great variety of physiological processes, from digestion, to 
blood coagulation/fibrinolysis, tissue organogenesis, neurohormone and cytokine maturation processing, among 
others. Several MCPs have been linked to human diseases, such as cancer, alzheimer disease, type 2 diabetes, 
acute pancreatitis and pancreas cancer, fibrinolysis and inflammation. Consequently, MCPs and their strong, 
small protein inhibitors have been of considerable medical interest as potential drug targets or effectors27, 28. The 
study of folding/unfolding pathways allows to gain insight into the essential elements that confer foldability and 
stability to MCPs inhibitors and is prerequisite for their production, minimization and redesign for biomedical 
and biotechnological purposes.
Nerita versicolor carboxypeptidase inhibitor (NvCI) is the strongest, natural proteinaceous inhibitor reported 
so far for the M14A subfamily of carboxypetidases, with inhibitory constants in the picomolar range29. It com-
prises 53 residues and a protein fold composed of a two-stranded antiparallel β-sheet connected by three loops 
and stabilized by three disulfide bridges: The Cys27-Cys38 disulfide bond interconnects the two major second-
ary structure elements; Cys9-Cys23 stabilizes the first beta sheet by fixing this element to the N terminus of the 
inhibitor and Cys15-Cys51 links the C terminal tail, which corresponds to the active site of NvCI, with the first 
loop (Fig. 1). This small protein was isolated from the marine snail Nerita versicolor and represents the first pro-
teinaceous inhibitor of MCPs isolated and characterized in depth from a marine organism29. Other proteinaceous 
carboxypeptidase inhibitors have been found in evolutionarily distant organisms such as potato (Potato carboxy-
peptidase inhibitor: PCI)30, the medical leech Hirudo medicinalis (leech carboxypeptidase inhibitor: LCI)31, the 
tick Rhipicephalus bursa (tick carboxypeptidase inhibitor: TCI)32 and the intestinal parasite Ascaris Suum (Ascaris 
carboxypeptidase Inhibitor: ACI)33, 34. The three-dimensional protein structures of these inhibitors are unrelated 
and completely different26, the only conserved motif being the structural conformation of the P1 and P2 residues 
in the C-terminal tail of the inhibitor that interacts in a competitive manner with the active site of the carboxy-
peptidase by occlusion of the active site subsites S1’, S1 and S235.
Here, we report a comprehensive analysis of the pathways of oxidative folding and reductive unfolding of 
NvCI. The characterization of the acid-trapped intermediates that accumulate along these two processes reveals 
the predominance of a few native disulfide-bonded intermediates that efficiently guide this protein toward its 
native conformation. These results identify NvCI as a protein with a BPTI-like oxidative folding under native 
conditions. However, when non-covalent interactions are nullified by the presence of denaturants, the protein 
is still able to fold efficiently through a “trial an error” mechanism resembling that of hirudin. Therefore, NvCI 
arises as a novel model to study the inherent plasticity of protein folding pathways.
Results
Oxidative folding of NvCI. Reduced and unfolded NvCI was allowed to refold in Tris-HCl buffer (pH 8.4), 
in the absence and presence of different redox agents. Folding intermediates were trapped at selected time points 
by either acid quenching with TFA or alkylation of the free SH groups. The heterogeneity and chromatographic 
behavior of the acid-trapped folding intermediates was characterized by RP-HPLC (Fig. 2a) and the disulfide 
bond content of the derivatized intermediates was determined by MALDI-TOF-MS analysis (Fig. 2b). In the 
absence of redox agents (control−), only few intermediates populate the folding reaction, with the accumulation 
of two major fractions, designated as I and II (Fig. 2a). The presence of 0.25 mM 2-mercaptoethanol (control+), 
which promotes disulfide rearrangement in oxidized species, did not affect the overall chromatographic pattern. 
However, if we compare the 4 h acid-trapped sample in both conditions, the recovery of native protein was higher 
in control+, indicating that the folding rate was slightly increased. Taking into account that NvCI belongs to 
the usually slow-folding small disulfide-rich protein class, its overall folding process was very efficient, allowing 
an almost complete recovery of the native protein after 8 hours of refolding both in the absence and presence of 
redox agent. Mass spectrometry analysis of disulfide species along NvCI folding reaction showed the formation of 
1-disulfide species (1S-S) within the first 4 hours of refolding, to reach a maximum around 2 to 3 hours (Fig. 2b). 
At this time point, an increase in 2-disulfide species (2S-S) started, reaching a maximum at about 6 to 8 hours, 
to finally convert into the 3-disulfide native end product (3S-S). Oxidative folding experiments are usually per-
formed at pH 8.4, because this is the pKa of the Cys amino acid side chain. In order to confirm that the protein 
folds through the same pathway at physiological pH, the refolding experiments were also performed in 0.1 M Tris 
at pH 7.4 both in the absence and presence of 2-mercaptoethanol (Supplementary Fig. S1a). In these conditions, 
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we detect exactly the same folding intermediates than at pH 8.4; despite, as expected, the folding reaction evolves 
slightly more slowly.
Oxidative folding of NvCI was subsequently performed in the presence of oxidized glutathione (GSSG) 
(0.5 mM) and a mixture of reduced and oxidized glutathione (GSH:GSSG, 1.0:0.5 mM, respectively). The 
RP-HPLC patterns obtained in both redox conditions were almost indistinguishable and the folding reaction pro-
gressed at very similar rates, indicating that the presence of the reducing agent (GSH) did not have a significant 
effect on NvCI folding (Fig. 2a). Consequently, the strong differences observed between the control experiment 
and those performed under redox conditions, could be attributed mostly to the oxidizing agent (GSSG). The 
presence of GSSG affected both the overall folding rate and the isoforms pattern. Native NvCI was almost fully 
formed after 1 hour, compared to the 8 hours required in the control experiment. Besides, folding intermediates 
I and II accumulated to a much greater extent and other minor intermediate species become detectable under 
these conditions. The fast oxidation of 1- and 2-disulfide species resulted in their accumulation, as it can be 
observed in the 10-min refolding time (Fig. 2b), when nearly 70% of the species are 1- or 2-disulfide forms, while 
in the control experiments the sum of these species hardly accounts for 40% of the conformers. In these oxidizing 
conditions intermediates I and II seem to behave as kinetic traps, their conversion becoming rate-limiting for the 
attainment of the native fold.
Protein folding reactions usually exhibit significant temperature dependence36. To test if this is the case for 
NvCI, we performed oxidative folding experiments on ice, in 0.1 M Tris.Cl pH 8.4, in the absence and presence of 
0.25 mM 2-mercaptoethanol. The samples were acid quenched at different timepoints and subjected to RP-HPLC. 
As expected, the folding reaction rates were significantly lower in these conditions, with only 30–40% of the 
native protein being recovered after 24 h (Supplementary Fig. S1b). Nevertheless, the pathway remained identical 
to that recorded at 25 °C in terms of the succession of folding intermediates.
To assess the disulfide bond content of the two major folding intermediates, they were purified by RP-HPLC, 
freeze-dried and alkylated either with 4-vinylpyridine (VP) or iodoacetamide (IAA). The intermediate fractions 
I and II displayed 4 and 2 reduced reactive cysteines, respectively. Therefore, intermediate I contains a single 
disulfide bond while intermediate II contains two disulfide bonds. The intermediate species that accumulated to a 
lesser extent were also purified from the 10-min GSSG acid-trapped sample. That is, the fraction eluting between 
the reduced protein and peak I (retention time from 39 to 45 min) and the fraction eluting between peak I and II 
(retention time from 35.5 to 37 min. See Fig. 6a for a summary of RP-HPLC fractions and disulfide content). MS 
analysis of the former showed that it contained mainly one-disulfide species, while the latter contained mainly 
two-disulfide species. Importantly, none of the one- or two-disulfide species elutes close to native NvCI indicat-
ing that under chromatographic conditions they are much less compact than the natively cross-linked form. In 
Figure 1. Schematic view of the native three-dimensional structure of NvCI and the NvCI-hCPA4 complex. (a) 
Schematic view of the ribbon representation of NvCI. The cysteine residues are depicted in the structure and the 
disulfide bonds are shown in stick representation (blue). The amino acid sequence of NvCI and its secondary 
structure elements and disulfide pairing are schematically shown at the bottom. The inhibitory site for MCPs 
comprises two residues (Tyr52 and Ala53), located at the C terminal tail, after Cys51. (b) Surface and ribbon 
representation of human CPA4 (hCPA4) in complex with NvCI (gray). The three disulfide bridges formed in 
NvCI are shown in stick representation (blue). The α-helix, β-strands, and coils of hCPA4 are highlighted in 
red, yellow, and green color, respectively. Ct and Nt stands for C terminus and N terminus, respectively. The 
Protein Data Bank accession number for the structure of NvCI in complex with hCPA4 is 4A94. All figures were 
prepared with PyMOL.
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addition, no alternative, scrambled, three-disulfide species populate the reaction in any of the assayed folding 
conditions.
To further characterize the conformational changes of the inhibitor along the folding process, the fully 
reduced/unfolded NvCI was allowed to refold in Tris-HCl (pH 8, 4) and the secondary and tertiary structural 
changes were monitored using far-UV CD and tryptophan emission fluorescence spectroscopy, respectively 
(Fig. 3). The only secondary structure element in native NvCI protein is a two-stranded antiparallel β-sheet29. 
Accordingly, as the protein folds, the far-UV CD intensity at 217 nm increases, reaching a maximum after 10 h 
when all the protein is in the folded state (Fig. 3). NvCI harbours a single tryptophan at position 42 in the second 
β-strand (Fig. 1a). In the native state, Trp42 is buried inside NvCI, being packed between the Cys9-Cys23 and 
Cys15-Cys51 disulfide bonds, which likely contribute to the quenching of its fluorescence. As a consequence, the 
intrinsic fluorescence intensity of the native state is much lower than that of the reduced/unfolded state, despite 
not detecting any differences in the emission maximum wavelength. When the protein was allowed to refold in 
the same conditions described above, we observed a decrease in the Trp42 fluorescence intensity along folding 
that again became stabilized after 10 h (Fig. 3b). The spectroscopic probes suggested that the formation of the 
β-strand upon folding is coupled to the burial of Trp42 in the native structure. The kinetics of secondary and 
tertiary structure formation are consistent with the population of the native state as measured by RP-HPLC.
Reductive unfolding of NvCI. The reductive unfolding of native NvCI was studied by using both dithioth-
reitol (DTT) at pH 8.4 and Tris(2-carboxyethyl)phosphine hydrochloride (TCEP) at pH 4.5, as reducing agents. 
The intermediates that accumulated along the unfolding reaction were trapped in a time-course manner by acid-
ification and analyzed by RP-HPLC. The addition of 1 mM DTT at pH 8.4 resulted in the reduction of the 3S-S 
native form in one hour (Fig. 4a), while incubation with 20 mM DTT resulted in complete protein reduction in 
less than 5 minutes (data not shown). Along the process, two minor fractions with HPLC elution times equivalent 
to that of intermediates I and II were detected. However, the extent of accumulation of these partially reduced 
species was much lower than that observed in oxidative folding, thus the unfolding reaction followed an apparent 
all-or-none mechanism37.
The use of TCEP at pH 4.5 as a reducing agent avoids disulfide bond isomerization during the reduction pro-
cess, resulting in a much stronger accumulation of intermediate II (Fig. 4b). The disulfide bond content of this 
species was assessed by RP-HPLC purification, alkylation and further MS analysis and, as expected, it turned to 
be a 2-disulfide species.
Reductive unfolding was also followed by monitoring the changes in tryptophan intrinsic fluorescence. The 
presence of DTT led to an increase in fluorescence intensity concomitant with the progression of the unfolding 
reaction, without a detectable shift in the spectra maximum wavelength (Fig. 4c, top). As expected, the rate of the 
Figure 2. RP-HPLC analysis of the folding intermediates and quantitative analysis of disulfide species along 
the oxidative folding pathway of NvCI. Folding was carried out in Tris-HCl buffer (pH 8.4) in the absence 
(Control−) and presence of selected redox agents: 0.25 mM 2-mercaptoethanol (Control+), 0.5 mM GSSG or a 
mixture of 0.5 mM GSSG and 1 mM GSH. (a) Chromatographic profiles of the folding reactions. Intermediates 
were acid-trapped at the noted times and analyzed by RP-HPLC. Retention times of the native (N) and fully 
reduced/unfolded (R) forms as well as the two major intermediates (I and II) are indicated. (b) Disulfide species 
in the oxidative folding of NvCI. Intermediates were trapped by alkylation of the free cysteines at various times 
and analyzed by MALDI-TOF-MS. 0S-S, 1S-S, 2S-S, and 3S-S represent the completely reduced, one disulfide, 
two disulfide, and three disulfide species, respectively.
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fluorescence emission increase was dependent on the concentration of DTT and the maximum spectrum area 
value was achieved at the time the protein becomes fully reduced. The comparison between the HPLC profile 
and the tryptophan spectrum of the 20-minute TCEP reduced sample gave us information about conformational 
properties of the intermediate II. The relative abundances of native NvCI, peak II and the reduced protein are 
57%, 36% and 7% respectively, as deduced from the HPLC pattern, but the total change in the tryptophan spec-
trum only represents a 14% at that time point. These results suggest that the tryptophan remains significantly 
buried in intermediate II (Fig. 4c, bottom).
Disulfide-pairing analysis of the major folding intermediates. After examination of the oxidative 
folding and reductive unfolding of NvCI, it was important to determine the disulfide pairings of the two main 
intermediates (i.e. I and II) that accumulate during the reactions. The intermediates were purified by RP-HPLC 
and subjected to a sequential alkylation-reduction-alkylation strategy, as described in methods. The protein 
reacted with a first alkylating reagent that can only label the available free cysteines and then the sample was 
reduced and alkylated with a second alkylating reagent, which labelled the cysteines that were initially protected 
owing to their participation in disulfide bonds. The double derivatized intermediates were subsequently digested 
with trypsin and subjected to MALDI-TOF and TOF-TOF analysis.
The results obtained for the sequential alkylation strategy of peak I (IAA-DTT-VP) are shown in Fig. 5a. 
The 2478.1 Da peak corresponded to a peptide with a single cysteine residue (Cys38) that was derivatized with 
VP, indicating that Cys38 participated in a disulfide bond. The 1715.8 Da peak correlated with a tryptic peptide 
containing 3 cysteines, two of them derivatized with IAM and one with VP. MALDI-TOF-MS2 sequencing of the 
peptide allowed the assignation of the pyridylethyl modification to cysteine 27 and with this result, it could be 
inferred that intermediate I contained a single native disulfide bond corresponding to that linking Cys27-Cys38 
(Fig. 5a).
A detailed comparison of the chromatographic profiles of oxidative folding and reductive unfolding of the acid 
trapped intermediates revealed that the reductive unfolding peak II (designated IIb from now on) was apparently 
homogeneous, whereas the oxidative folding peak II (designated IIab from now on) was heterogeneous, contain-
ing at least two different 2-disulfide species (Fig. 6a and b). Considering the heterogeneity of fraction IIab coming 
from oxidative folding, it was essential to separate these species for the disulfide pairing analysis. Therefore, the 
whole fraction IIab was purified by RP-HPLC, subjected to a first alkylation step (VP or IAA) and the resulting 
species were repurified by RP-HPLC (Fig. 6c). The two main derivatized fractions (a and b) were freeze-dried, 
reduced with DTT, subjected to a second alkylation step (IAA or VP), digested with trypsin and analyzed by 
MS. In Fig. 5b, is shown the disulfide pairing characterization of the purified II-b-PE fraction. Starting with a 
purified intermediate, in which the free cysteine residues had been blocked previously with VP, the disulfide 
bonds were reduced by DTT and the resultant thiols alkylated with IAA and subjected to trypsin digestion. 
The 1679.8 Da and the 2430.1 Da peaks corresponded to peptides containing 1 cysteine derivatized with IAM, 
indicating that their cysteine residues (Cys9 and Cys38) originally participated in disulfide bonds. On the other 
hand, the 617.2 Da peak matched with a peptide with a single cysteine derivatized with VP (Cys51), implying that 
Cys51 was free in intermediate IIb. The 1715.8 Da peak, corresponded to a peptide with 3 cysteines, two of them 
modified with IAM and one with VP. The MS/MS analysis led to the assignation of the cysteine modifications, 
concluding that Cys15 was the one derivatized with VP and thus, the one that was free in the intermediate, while 
Figure 3. Secondary and tertiary structural changes upon oxidative folding of NvCI. The secondary and 
tertiary structure changes along folding time were monitored by far-UV CD and tryptophan fluorescence 
spectra measurements, respectively. The fully reduced/unfolded protein was allowed to refold in 0.1 M Tris-
HCl pH 8.4 at 20 °C. (a) Plot of ellipticity at 217 nm as a function of folding time. Inset: Far-UV CD spectra at 
different time points along folding. (b) Tryptophan spectrum area changes as a function of folding time. Inset: 
Tryptophan fluorescence spectra at different time points along folding. The arrow indicates the progression of 
the folding reaction along time.
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Cys23 and Cys27 were modified with IAM and thus participated in the disulfide bonding of the IIb form. The 
same MALDI-TOF-MS and MS2 results depicted in Fig. 5b, could have been observed if the intermediate II-b-PE 
had harboured 2 non-native disulfides. We excluded this possibility when we analyzed by the same strategy, the 
purified homogeneous fraction IIb obtained from reductive unfolding experiments with 20 mM TCEP at pH 4.5. 
The fraction IIb elutes in the same position than IIab (Fig. 6b). We knew beforehand that this species could only 
contain two native disulfide bonds and we obtained exactly the same results as described above. Therefore, the IIb 
species comprises two native disulfide bonds: Cys9-Cys23 and Cys27-Cys38, and will be designated henceforth 
des(15–51).
The disulfide pairing characterization of the purified II-a-CM fraction is shown in Fig. 5c. The detection of the 
1679.8 Da peak indicated that Cys9 was free, while the 2478.1 and 612.7 Da peaks revealed that Cys38 and Cys51 
were forming part of disulfide bonds. The MS/MS sequence analysis of the 1763.8 Da fragment, showed that 
Cys23 was initially a free cysteine, while Cys15 and Cys27 were disulfide bridged. Thus, the remaining 2-disulfide 
species of fraction IIab contained the Cys15-Cys51 and Cys27-Cys38 native disulphide bonds, designated from 
now on as des(9–23).
Integration of the IIab derivatives HPLC peak areas (Fig. 6c, left and right insets) allowed us to estimate that 
des(15–51) (fraction II-b) accounted for 60–70% while des(9–23) (fraction II-a) corresponded to 30–40% of the 
native 2-disulfide oxidative folding intermediates. Both intermediates share the native Cys27-Cys38 disulfide 
present in intermediate I, and no prevalent intermediate without this covalent link was detected.
Stop-go folding of the major intermediates of NvCI. To further assess the kinetic roles of NvCI 
folding/unfolding intermediates, we performed stop-go experiments on the purified species. Fraction I 
(Cys27-Cys38), IIb (des(15–51) and IIab (comprises des(15–51) and des(9–23)) were freeze-dried and allowed 
to resume its folding at pH 8.4 in the absence and presence of GSSG. For all tested intermediates, GSSG strongly 
accelerated the conversion to the native protein, which was almost completed 30 min after resuming folding 
(Fig. 7a). The stop-go folding profiles of intermediate I, showed that it rapidly reached an equilibrium with frac-
tion IIab and other minor 1 and 2-disulfide isomers, equivalent to the ones observed in NvCI oxidative folding 
(see Fig. 2a).
The overall refolding profiles of intermediates IIb and IIab in the presence of GSSG were similar. The purified 
des(15–51) intermediate (IIb) only requires the formation of the Cys15-Cys51 disulfide to yield native NvCI. In 
case it was the productive species, in the presence of GSSG it would form a mixed disulfide with glutathione and 
subsequently, a thiol disulfide exchange with the remaining cysteine thiol to form the last native disulfide bridge 
and render native NvCI. However, after 1 min of refolding, peak broadening was observed, obtaining a similar 
peak profile to that of fraction IIab at the same time point, which indicates that des(15–51) was in rapid equi-
librium with des(9–23). Moreover, the des(15–51) species was also in equilibrium with three minor 2 disulfide 
isomers, as characterized before (see Fig. 6a, peaks with retention time from 35.5 to 37 min), consistent with the 
intramolecular rearrangement of des(15–51) to des(9–23) likely involving a reshuffling reaction in which minor 
2-species can be populated.
The stop-go folding reaction at pH 8.4 in the absence of GSSG was slower for all NvCI folding intermedi-
ates (Fig. 7b). Interestingly, during the refolding of des(15–51) the population of 2 and 1 disulfide native and 
non-native intermediates as well as of the reduced protein was observed. Therefore, in the absence of an oxidizing 
agent that accelerates covalent crosslinking, des(15–51) enters in equilibrium with all the species that populate 
the oxidative folding of NvCI. In contrast, the refolding of fraction IIab in the same conditions neither showed an 
interconversion with 1-disulfide species, nor with the fully reduced protein.
Figure 4. Reductive unfolding of native NvCI. Native NvCI was treated with: (a) 1 mM DTT in Tris-HCl (pH 
8.4) and (b) 20 mM TCEP in sodium acetate (pH 4.5). Time course intermediates were trapped by acidification 
and analyzed by RP-HPLC. N and R stand for native and reduced NvCI; II for an intermediate that accumulates 
upon reduction with 20 mM TCEP. (c) Reductive unfolding of native NvCI followed by changes in tryptophan 
fluorescence spectra, after the addition of reducing agents. Native NvCI was reduced with TCEP (20 mM) in 
sodium acetate pH 4.5 (graph below) and DTT (1.0 and 20 mM) in Tris.Cl pH 8, 4 (graph above). Tryptophan 
fluorescence spectra were measured over time and the spectrum area was plotted as a function of time.
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Conformational Stability of NvCI. The oxidative folding reaction was performed in the presence of 6.0 M 
urea in 0.1 M Tris-HCl (pH 8.4) and the intermediates were acid-trapped in a time course manner and examined 
by RP-HPLC. As shown in Fig. 8, in these strongly denaturing conditions, the oxidative folding reaction pro-
ceeded without loss of native protein recovery, being almost complete after 24 h of incubation. In comparison 
with the folding reaction without denaturant (Fig. 2a), the presence of 6.0 M urea decreased the accumulation of 
native 1-disulfide and 2-disulfide intermediates, while other intermediates, probably comprising non-native 1S-S 
and 2S-S species populated the reaction. In the presence of 6.0 M urea, the addition of 1 mM GSSG to the folding 
Figure 5. Disulfide-pairing determination of the major oxidative folding intermediates of NvCI. CM stands 
for carboximethyl cysteine (alkylated with IAA) and PE stands for pyridylethyl cysteine (alkylated with VP). 
The cysteine positions are indicated above the graph. (a) Characterization of fraction I: The purified fraction 
I was derivatized with IAA, reduced with DTT and further derivatized with VP prior trypsin digestion. 
The molecular masses determined by MALDI-TOF-MS for the derivatized tryptic peptides are shown. The 
1715.8 Da derivatized peptide was sequenced by MALDI-TOF-MS2 and the spectrum characterized by β and γ 
ion series with the assigned sequence is shown. (b) Fraction IIb characterization: The purified IIab fraction was 
derivatized with VP and purified by RP-HPLC (see Fig. 5c, II b-PE). Then it was reduced with DTT, derivatized 
with IAA and subjected to trypsin digestion and MALDI-TOF analysis. The 1715.8 Da fragment was sequenced 
by MALDI-TOF-MS2 and the spectrum with the assigned sequence is shown. (c) Fraction IIa characterization: 
The purified IIab fraction was derivatized with IAA and purified by RP-HPLC (see Fig. 5, II a-CM). Then it 
was reduced with DTT, derivatized with VP and subjected to trypsin digestion and MALDI-TOF analysis. The 
1763.8 Da fragment was sequenced by MALDI-TOF-MS2 and the assigned sequence is shown.
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reaction drastically accelerated native protein recovery that was almost complete after 1 h, a time equivalent to 
the one needed under non-denaturing conditions (Fig. 2a). NvCI was able to attain its native state even in the 
presence of 4.0 M guanidine hydrochloride (Gdn.HCl) (Fig. 8), with almost a complete conversion after 24 h 
of refolding in Tris-HCl pH 8.4. Again, the identity of the intermediates populated along the reaction changed 
relative to those observed under non-denaturing conditions. As in the case of urea, the presence of 1 mM GSSG 
greatly accelerated the folding reaction, which proceeded in a timeframe equivalent to this observed under native 
conditions.
Next, we proceeded to analyze the conformational stability of NvCI using the technique of disulfide scram-
bling. It has been well established that when disulfide-containing proteins are treated with denaturants in the 
presence of a thiol initiator, their unfolding results in reshuffling of their native disulfide bonds, leading to the for-
mation of disulfide-scrambled species38, 39. On this basis, native NvCI was incubated in the presence of 0.25 mM 
2-mercaptoethanol as a thiol initiator and increasing concentrations of urea, Gdn.HCl or guanidine thiocyanate 
(Gdn.SCN) at pH 8.4. The protein mixtures were allowed to reach equilibrium for 20 h, trapped by acidification 
and analyzed by RP-HPLC (Fig. 9).
The extent of native NvCI unfolding was clearly dependent upon the strength of the denaturant, as previously 
described for other protein models38, 40. Urea was unable to denature native NvCI, and even in the presence of 
8.0 M urea no scrambled isomers were detected (Fig. 9a). On the other hand, both Gdn.SCN and Gdn.HCl had 
a strong effect on NvCI disulfide scrambling promoting the reshuffling of native NvCI into scrambled isomers. 
Figure 6. Derivatization and HPLC isolation of two 2 S-S folding intermediates of NvCI. (a) Comparison 
of RP-HPLC profiles of oxidative folding and reductive unfolding. Fraction II of oxidative folding (IIab) and 
fraction II of reductive unfolding (IIb) elute at the same retention time. The disulfide bond content of all 
folding intermediates are indicated. (b) Superimposition of oxidative folding and reductive unfolding RP-
HPLC chromatograms, showing the elution position and the heterogeneity of fraction IIab. The RP-HPLC was 
performed using a C4 column as described in methods. (c) The fraction corresponding to IIab, composed at 
least by two species (a and b), was purified by RP-HPLC in a C8 column, freeze-dried and derivatized either 
with VP or IAA. Two major species of each derivatized IIab fraction were further purified by RP-HPLC (left 
and right insets). An inversion of the order of peaks elution was observed after derivatization. PE stands for 
pyridylethyl species (akylated with VP) and CM stands for carboximethyl species (alkylated with IAA).
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The midpoint denaturant concentrations for Gdn.SCN and Gdn.HCl were 3.0 M and 6.5 M, respectively (Fig. 9b). 
The native protein was completely denaturated at 5.0 M Gdn.SCN and three scrambled isomers, which account 
for 95% of total denatured NvCI could be distinguished (Peaks a, b and c. Fig. 9a). The same isomers could be 
observed using Gdn.HCl as denaturant. Peaks a, b and c were purified by RP-HPLC, freeze-dried, reacted either 
with VP or IAA and further analyzed by MALDI-TOF-MS to confirm the disulfide bond content of the scrambled 
isomers. As expected, all the scrambled species contained three disulfide bonds and none of them reacted with the 
alkylating reagents. The high retention of these species in the RP-HPLC profile relative to native NvCI indicate, 
that under chromatographic conditions, they are significantly less compact.
Functional and conformational characterization of des(15–51) NvCI. Fraction IIb (des(15–51)) 
together with the native NvCI protein, were purified by RP-HPLC from the acid-trapped 20 min sample of reduc-
tive unfolding with 20 mM TCEP at pH 4.5. The purified intermediate as well as the native protein were quantified 
by absorbance at 280 nm and freeze-dried. Samples were resuspended at 1 mg/ml in H2O/D2O (9:1 ratio, pH 2.0) 
and subjected to monodimensional NMR. The NMR spectrum of des(15–51) displayed a wide signal dispersion 
of resonances at both low (amide and aromatic region) and high (methyl region) fields, with good peak sharpness, 
characteristic of a compact molecule, despite the signal dispersion was somehow smaller than that exhibited by 
the native protein (Supplementary Fig. S2). The comparison of the one-dimensional NMR spectra of NvCI and 
des(15–51) suggests that the intermediate retains a significant amount of native structure, consistent with its 
partial resistance to reduction and the quenching of the Trp residue, but is likely more disordered and/or flexible 
than the native inhibitor.
Figure 7. Stop/go folding of the major folding/unfolding intermediates of NvCI. Acid-trapped intermediates 
(I, IIb and IIab) were purified by RP-HPLC, freeze-dried, and dissolved in Tris-HCl (pH 8.4) to reinitiate 
the folding reaction either in the absence (b) or presence (a) of 1 mM GSSG. Folding intermediates were 
subsequently trapped with acid at different time points and analyzed by RP-HPLC. The chromatograms at 
0 minutes (shown in a) were obtained after resuspending the lyophilized intermediates in TFA 1% as a control of 
purity and homogeneity of each species.
Figure 8. Oxidative folding of NvCI in the presence of high denaturing conditions. The fully reduced/unfolded 
protein was allowed to refold in Tris-HCl buffer (pH 8.4) in the presence of: 6.0 M urea; 1 mM GSSG in 6.0 M 
urea; 4.0 M Gdn.HCl and 1 mM GSSG in 4.0 M Gdn.HCl. Intermediates were acid-trapped at the noted times 
and analyzed by RP-HPLC. The elution positions of native (N) and reduced (R) NvCI are indicated.
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NvCI is a novel tight-binding, competitive inhibitor of MCPs, which displays the strongest inhibitory con-
stants described (in the picomolar range) against most CPA-type forms29. The lower Ki values observed for NvCI 
compared to other MCP inhibitors were previously attributed to both the primary and secondary interaction 
regions, which create an extended interface with the carboxypeptidase enzyme that minimizes the product release 
of the catalytic reaction29. The primary contact region of the inhibitor corresponds to the C-terminal tail (Tyr52 
and Ala53) together with the main chain of Cys51, whereas the secondary contact region is very extended and 
coincides with the exoface of the NvCI β-sheet.
Inhibition constants for the complexes of native NvCI and the des(15–51) intermediate with different carboxy-
peptidases were determined (Table 1). The inhibitory activities of the intermediate des(15–51) against human 
CPB1 and porcine CPB1 were one order of magnitude lower than that of NvCI, but the intermediate still acts 
as a tight-binding inhibitor for B type carboxypeptidases, with Ki in the nanomolar range. Native NvCI showed 
inhibition constants in the picomolar range for human CPA1 and bovine CPA1, in agreement with our previous 
data29. The inhibitory capability of the intermediate des(15–51) for both type A tested carboxypeptidases was 
three orders of magnitude lower than the native form, but again it displayed Ki in the nanomolar range, showing 
that it behaves as a tight-binding inhibitor for these enzymes. This is relevant because the Cys15-Cys51 disulfide 
bond was supposed to immobilize the C-tail of NvCI as a requirement for a proper inhibition. Interestingly, the 
side chain of Glu-163 in hCPA4 forms favorable hydrogen bond contacts with the amino groups of Cys-51 and 
Tyr-52 of NvCI29.
Discussion
Different models have been proposed to explain the cooperativity of protein folding transitions. Seminal oxidative 
folding studies by the laboratories of Creighton, Kim, Scheraga, and Chang using BPTI, RNase A and hirudin as 
model proteins contributed significantly to the experimental validation of these theoretical models3, 10, 25, 41. The 
framework model and the hydrophobic collapse model represent two extreme canonical and generic descrip-
tions of the protein folding process. The BPTI folding is in line with the framework model42, 43, which stresses 
the importance of local interactions in reducing conformational search and in guiding efficient protein folding 
through the hierarchic condensation of native-like elements. In contrast, the hirudin folding is consistent with 
the hydrophobic collapse model44, which depicts protein folding as an initial stage of rapid hydrophobic collapse 
followed by searching of conformations in which specific interactions refine the structure rather than dominate 
the folding code22, 45. It is still unclear which features of the primary structure of a small, disulfide-rich protein, 
influence its type of folding, since proteins sharing the same conformation and disulfide connectivity fold through 
different pathways and, conversely, proteins with different structural features turn to share the same type of fold-
ing reaction46. This fact highlights the need for new and detailed studies to gain insights into the molecular rules 
that govern the folding process.
Figure 9. Disulfide scrambling of NvCI under different concentrations of denaturants. (a) The native form 
of NvCI was denatured in Tris-HCl buffer (pH 8.4) containing 0.25 mM 2-mercaptoethanol as thiol initiator 
and the indicated concentration of denaturants at 20 °C for 20 h. The denatured samples were quenched with 
2% TFA and analyzed by RP-HPLC. The fractions a, b and c correspond to non-native (scrambled) isomers of 
NvCI. (b) Native fraction as a function of denaturant concentration. Denaturation of native NvCI is defined by 






hCPA1 0.00118 ± 0.00039 1.00 ± 0.08
bCPA1 0.00491 ± 0.00064 2.01 ± 0.14
hCPB1 0.62 ± 0.04 7.85 ± 0.55
pCPB1 0.53 ± 0.04 4.90 ± 0.28
Table 1. Summary of Ki values of native and des(15–51) intermediate against various carboxypeptidases. Data 
are means (n = 3) ± S.D. Inhibition assays were carried out at 37 °C.
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In the current work we have comprehensively analyzed the pathways of oxidative folding and reductive 
unfolding of NvCI. Although 75 different disulfide-bonded intermediates are theoretically possible, only a few 
species populate significantly the oxidative folding reaction of this inhibitor. Importantly, all major intermediates 
contain one or two native disulfide bonds, suggesting a strong bias toward the establishment of native-like inter-
actions during folding under close to physiological conditions. Therefore, for NvCI, folding appears to proceed 
through the sampling of a reduced number of specific metastable states rather than through a large conforma-
tional search among species of similar free energy. CD and Trp fluorescence data indicates that this progressive 
acquisition of native disulfide bonds is concomitant with the formation of native secondary and tertiary NvCI 
structure. The presence of a discrete number of natively bonded intermediates, together with the lack of signifi-
cant scrambled isomers, would account for the high efficiency of NvCI folding, when compared with proteins of 
similar size and disulfide content47. It is worth to clarify, however, that despite its relative efficiency, the in vitro 
folding of NvCI takes hours to complete. It is expected that during catalysed cotranslational oxidative folding 
in the endoplasmic reticulum the reaction would be completed in significantly shorter times; despite some evi-
dences indicate that even in these favourable conditions disulfide-containing proteins fold much slower than 
proteins devoid of this covalent link48.
The predominant folding pathway followed by NvCI at pH 8.4 is summarized in Fig. 10. Initially, reduced 
NvCI is oxidized to a mixture of one-disulfide species, with a high prevalence of the Cys27-Cys38 form that com-
prises the shortest loop closed by native disulfides. Thus, the configurational entropic contribution of this linkage 
to the stability of one-disulfide intermediates is the lowest among those provided by native disulfide bonds. The 
abundance of this intermediate cannot be explained simply on the basis of the sequential vicinity of Cys, because 
in this case one-disulfide intermediates containing the non-native Cys23-Cys27, Cys9-Cys15 or Cys15-Cys23 
bonds would be more prevalent and they could not be detected. Therefore, the population of the Cys27-Cys38 
species likely responds to the establishment of preferential noncovalent interactions between residues surround-
ing these specific Cys residues. This disulfide bond links the C-terminus of the β-strand 1 to the N-terminus of the 
adjacent β-strand 2 in the antiparallel β-sheet of NvCI, the only regular secondary structure in this small protein. 
Prediction of the secondary structure propensities in NvCI sequence using GOR V49 indicates an intrinsic β-sheet 
propensity for the segments 24–28 and 36–45, whereas PSIPRED50 predicts the stretches 24–29 and 37–45 as 
β-strands, both predictions overlapping with the two β-strands in the NvCI crystal structure, which comprise 
residues 22–29 and 36–44, respectively. In agreement with the crystal structure, none of the two algorithms pre-
dict secondary structure propensity in other regions of the NvCI sequence. Both Cys27 and Cys38 are inside the 
predicted β-strands, suggesting that a significant secondary structure bias in these stretches is responsible for the 
initial formation of the disulfide bond in the Cys27-Cys38 species. Subsequently, the covalent crosslink would 
contribute to stabilize the β-sheet.
Three main factors influence the reactivity of a disulfide bond, i.e, its electrostatic environment, the geometry 
of the bond and its burial. We minimized the isolated inhibitor structure using the Fold-X force field51 to analyze 
the potential contribution of these factors to the reactivity of the Cys27-Cys38 disulfide. No charged residues 
exist close to this covalent link that could affect its electrostatic environment, but the disulfide strain energy in 
Figure 10. Schematic representation of the disulfide oxidative folding pathway of NvCI. The polypeptide 
backbone and the β-sheets of the protein are depicted by lines and arrows, respectively. The positions of the six 
cysteine residues are indicated (SH: 9, 15, 23, 27, 38 and 51) and the disulfide bonds are depicted as solid lines. 
The RP-HPLC chromatogram and the major disulfide intermediates are depicted and the disulfide bond content 
of all the RP-HPLC fractions are indicated below the graph. The solid lines represent the productive disulfide 
folding pathway proposed.
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the native state for this bond is very high (15.77 kJ/mol), suggesting that it would be reactive if accessible to sol-
vent. This indicates that it should be at least partially buried to allow the accumulation of intermediate I as the 
major species in the 1S-S ensemble. The formation of a native-like β-sheet in the intermediate might account 
for this effect, since, in the native state, it completely buries Cys27, with less than 2% of its side chain exposed to 
solvent. Nevertheless, stop-go experiments on the isolated intermediate indicate that, despite its prevalence, the 
Cys27-Cys38 disufide bond is not completely secure and reshuffling reactions allow the formation of other 1S-S 
species at the beginning of the refolding reaction, especially in the absence of GSSG. Indeed, intermediate I does 
not accumulate during reductive unfolding reactions, even at acidic pH, which indicates that, in the absence of 
the other two native disulfides, at least one of its two Cys becomes accessible to the reducing agent. Thus, disulfide 
stapling of the β-sheet does not guaranties, per se, its stability.
In the next step of the NvCI oxidative folding, one-disulfide intermediates oxidize a second pair of cysteines to 
form two-disulfide intermediates that accumulate mainly as des(9–23) (intermediate IIa) and des(15–51) (inter-
mediate IIb), both of them containing two native disulfide bonds and sharing the Cys27–Cys38 crosslinking; thus 
suggesting that they evolve directly from oxidation of intermediate I. Despite RP-HPLC analysis indicate that 
these two 2S-S intermediates should display very similar compactness, des(15–51) is the only intermediate that 
populates the reductive unfolding reaction at acidic pH in the presence of TCEP, where reshuffling is impeded; 
thus indicating that the 9–23 disulfide bond is less reactive in the native inhibitor than the 15–51 one. An inspec-
tion of the NvCI structure suggests that both disulfide bonds are protected from the solvent to approximately the 
same extent, with Cys9 and Cys15 deeply buried in the structure. However, in the crystal structure of the inhibi-
tor/enzyme complex, Cys15-Cys51 disulfide is covered by the inhibitor C-tail only because it is docked and fixed 
in the active site of the carboxypeptidase moiety. We used the CABS-FLEX52 algorithm to simulate the structural 
flexibility of non-bound NvCI and the generated structural models strongly suggest that the C-tail would be 
flexible in solution and not expected to establish significant contacts with the rest of the domain (Supplementary 
Fig. S3), as described for most MCPs inhibitors, exposing at least partially the Cys15-Cys51 disulfide bond. From 
an entropic point of view, des(9–23) would be expected to be less destabilized, relative to the native state, that 
des(15–51) since the Cys15-Cys51 disulfide bond closes by far the longest loop in NvCI. The log n rule of Darby 
and Creighton53, predicts a destabilization of 2.9 and 3.8 kcal·mol−1 for des(9–23) and des(15–51), respectively; 
thus supporting that local disulfide protection, in at least a partially buried context and not the overall conforma-
tional stability of the intermediate would account for the higher resistance to reduction of the des(15–51) species. 
This is consistent with des(15–51) retaining a compact native-like conformation according to both NMR and 
carboxypeptidase inhibition assays.
Unexpectedly, stop/go experiments indicate that des(15–51) is not the productive 2S-S species, since NvCI 
native structure cannot be simply acquired by direct oxidation of the free Cys15 and Cys51 thiol groups. Indeed, 
isolated des(15–51) loss one or even two of its native disulfides before the reaction can proceed towards the 
formation of IIab and, latter on, towards the native ensemble, indicating that its disulfide bonds are available for 
intramolecular attack by their own thiols and, thus, that it is a disulfide-insecure intermediate. In the absence 
of the Cys15-Cys51 entropic restriction, the segment Gln39-Ala53 lacks any covalent connectivity with the rest 
of the molecule and would likely experiment conformational fluctuations that could conduct the free Cys51 to 
transiently reside close to preformed disulfide bonds, promoting reshuffling reactions. This agrees with the obser-
vation that, when reductive unfolding is performed at pH 8.4, where reshuffling is permitted, this intermediate 
does not accumulate anymore. This will explain why, during the folding reaction, the conversion of 2S-S species 
towards the native state is accelerated in the presence 2-mercaptoethanol (Fig. 2), since it favours reshuffling and 
also why when oxidation is favoured in the presence of GSSG, natively cross-linked 2S-S species accumulate sig-
nificantly before they can be converted into native NvCI. The formation of des(9–23) from des(15–51) involves 
the population of detectable less compact non-native 2S-S intermediates, even in the presence of GSSG, but these 
species do not accumulate significantly. It is likely that des(9–23) would act as the productive 2S-S species, which 
would be consistent with the non productive des(15–51) intermediate being the more abundant species in the 
IIab fraction. However, the impossibility to purify des(9–23) in an unmodified form to perform stop/go analysis 
does not allow to fully discard a potential involvement of non-native 2S-S species in the formation of functional 
NvCI.
Although under physiological conditions the folding reaction of NvCI is under kinetic control, the formation 
of metastable natively-linked 2 disulfide intermediates is not a requirement for the attainment of the functional 
structure of this small protein. As evidenced by the fact the protein folds efficiently to the native state even in the 
presence of 6.0 M urea or 4.0 M Gdn.HCl, where no preferential intermediate accumulates but rather a hetero-
geneous mixtures of conformers populates the reaction. Disulfide scrambling experiments indicate that in this 
stringent conditions the protein is folded, suggesting that the folding of NvCI can also be under thermodynamic 
control. In these conditions, it is difficult to postulate that the formation of the small secondary structure in NvCI 
would funnel the reaction by establishment of native-like preferential interactions and a mechanism of “trial 
and error” would more likely apply. Despite the presence of multiple intermediates, the formation of NvCI in 
the presence of denaturants is fast and efficient. This suggests that the lack of specific noncovalent interactions 
is compensated by the fast formation and rearrangement of disulfide bonds within the different populations of 
intermediates and likely by the absence of scrambled isomers, which usually delay folding reactions. Indeed, the 
scrambled isomers formed under disulfide scrambling conditions are significantly more retained in the RP-HPLC 
column than the native form, indicating that are significantly less compact than the functional form and that in 
case they would exist their disulfides would be significantly more exposed.
The ability to fold into the native state under strong denaturing conditions is not unique of NvCI and other 
small disulfide-rich proteins have been shown to attain the native state to some extent in the presence of chao-
tropic agents. However, the efficiency of NvCI is unprecedented. PCI exhibit an efficiency of 2.5 and <1% in the 
presence of 8.0 M urea and 5.0 M Gdn.HCl, respectively40. For hirudin, 8% of active protein is recovered in 5.0 M 
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Gdn.HCl54. In these conditions, the initial intermediates are likely formed stochastically and the initial nonspe-
cific collapse would represent a first rate limiting step for the formation of the first disulfide bonds. The sequence 
of NvCI is one of the most hydrophobic among small disulfide-rich proteins, with a grand average hydrophobicity 
score (GRAVY) value of −0.27, whereas PCI and hirudin display GRAVY values of −0.64 and −0.88, respec-
tively. The higher hydrophobicity of NvCI might well account for a more efficient collapse at the early stages of 
folding, resulting in the fast formation of a mixture of native and non-native disulfides that would subsequently 
rearrange to attain the thermodynamically more stable native topology. Indeed, the conformational stability of 
NvCI, as measured by the method of disulfide scrambling, is one of the highest among small proteins with three 
disulfides (Supplementary Table S1), being comparable to that of BPTI.
The folding reaction of NvCI provides an extreme example of the plasticity of folding pathways, since the func-
tional native state can be attained following different folding routes that hinder on very different folding mecha-
nisms being under kinetic or thermodynamic control depending on the protein microenvironment. It is largely 
assumed that the same interactions that stabilize the native structure also guide folding. However, certain proteins 
can arrive to the same folded state following alternative pathways involving a different succession of native-like 
interactions55. The case of NvCI is more dramatic since it can fold both through a succession of native-like con-
tacts or independently of this kind of interactions. Thus for NvCI it is both true that protein conformational 
folding drives disulfide formation and the other way around. However, it is unlikely that these two alternative 
pathways could coexist under physiological conditions, since single molecule force spectroscopy studies in the 
presence of oxidative folding catalysts like PDI and DsbA strongly support conformational folding preceding Cys 
oxidation56, 57.
Overall, in the present work we delineate the determinants of the foldability, stability and activity of NvCI, 
providing the basis for the further re-design of this tight binding inhibitor.
Methods
Protein expression and purification. Recombinant NvCI was overexpressed and secreted into the extra-
cellular medium using the Pichia Pastoris heterologous system as previously described29. After centrifugation 
at 6000 g for 15 min the culture supernatant was adjusted to pH 3.2 with HCl in 0.02 M sodium citrate buffer 
and filtered through a 0,8 µm membrane filter (Millipore). The culture supernatant was then loaded onto an 
ion-exchange chromatography column (1.6 × 10 cm, STREAMLINE Direct HST, GE Healthcare) connected to an 
AKTA purifier system (GE Healthcare). The column was equilibrated with 0.1 M sodium citrate (pH 3.2) and elu-
tion was performed increasing gradually the pH applying a 20 column volumes lineal gradient, from 0% to 100% 
0.1 M sodium phosphate (pH 8.0). The protein sample was then subjected to a size exclusion chromatography in a 
HiLoad 26/60 superdex 30 prep-grade column equilibrated in PBS buffer. The purity of the isolated inhibitor was 
determined by Tris-Tricine/SDS-PAGE, RP-HPLC and matrix-assisted laser desorption/ionization time-of-flight 
(MALDI-TOF) mass spectrometry (MS). The concentration of purified NvCI was determined by measuring the 
absorbance at 280 nm using a molar extinction coefficient of 8855 M−1 cm−1.
Oxidative Folding and Reductive Unfolding Experiments. Purified native NvCI (1 mg/ml) was 
reduced and unfolded by incubation in 0.1 M Tris-HCl (pH 8.4) containing 6.0 M GdnHCl and 200 mM DTT 
for 3 h at RT. To initiate refolding, we loaded the fully reduced/unfolded protein onto a HiTrap desalting column 
(GE Healthcare) connected to an AKTA purifier system that was previously equilibrated with 0.1 M Tris-HCl (pH 
8.4). The protein was eluted in 1.2 ml of equilibration buffer (protein concentration ~0.5 mg/ml) and incubated 
at RT in the absence (Control−) and in the presence of redox agents: 0.25 mM 2-mercaptoethanol (Control+), 
0.5 mM GSSG, or 0.5 mM/1.0 mM GSSG/GSH. Some refolding experiments were carried out in the presence of 
denaturants, in these cases, the eluted protein was incubated in 6.0 M urea or 4.0 M Gdn.HCl, in the presence or 
absence of 0.5 mM GSSG. The refolding reaction was monitored by removing aliquots of the sample at various 
time intervals and quenching them with 2% aqueous trifluoroacetic acid (TFA). Acid-trapped intermediates were 
subsequently analyzed by RP-HPLC using a linear 20–40% gradient of acetonitrile with 0.1% TFA over 50 min 
in a 4.6-mm C4 column (Phenomenex) at a flow rate of 0.75 ml/min. The reactions were performed in triplicates 
at 25 °C.
In reductive unfolding experiments, native NvCI (0.5 mg/ml) was incubated at RT in either 0.1 M Tris-HCl 
(pH 8.4) containing different concentrations of DTT (1.0 and 20 mM) or 0.1 M sodium acetate (pH 4.5), with 
20 mM TCEP. To monitor the unfolding reaction, time course aliquots of the samples were trapped with 2% 
TFA acid and similarly analyzed by RP-HPLC in a C4 column. To monitor the disulfide species along the 
unfolding process, folding intermediates were trapped in a time-course manner by alkylation with either 0.1 M 
4-vynilpyridine (VP) or 0.1 M iodoacetamide (IAA) for 45 min at RT in the dark. The derivatized samples were 
diluted 1:10 in 1% TFA acid to stop the reaction and analyzed by MALDI-TOF-MS. Each free cysteine that reacts 
with VP (pyridylethyl (PE) cysteine derivative) or IAA (carbamidomehtyl (CM) cysteine derivative) increases its 
molecular mass by 105.1 Da or 57.0 Da, respectively. The percentage of disulfide species along the folding process 
was calculated by integrating the peak areas corresponding to each disulfide species observed in the mass spec-
trum. The reductive unfolding experiments were performed in duplicates at 25 °C.
Disulfide-bond content and disulfide pairing analysis of the major intermediates of oxidative 
folding and reductive unfolding of NvCI. The acid-trapped intermediates were purified by RP-HPLC 
and freeze-dried. The free cysteines of the purified intermediates were blocked by derivatization with an alkyl-
ating reagent. Each sample (20–40 µg) was derivatized with either 0.1 M VP or 0.1 M IAA, in Tris–HCl (pH 8.4) 
at RT for 45 min in the dark. An aliquot of the samples was analyzed by MALDI-TOF-MS, to characterize the 
number of disulfide bonds of the folding intermediates. The derivatized samples were then freed form reagents 
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using Zip-Tip C4 pipette tip (Millipore), evaporated, and the disulfide bonds were reduced by resuspending the 
dried samples in 10 µl of 10 mM DTT in 0.1 M Tris-HCl (pH 8.4) and incubating for 1 h at RT.
The free cysteines, corresponding to those initially involved in disulfide bridges, were then subjected to a 
second alkylation reaction by adding 10 µl of the alkylating reagent not used in the first reaction and the samples 
were incubated for 1 h at RT in the dark. Then, the double-derivatized samples were purified by Zip-Tip C4 and 
air-dried. The dried samples were resuspended in 10 µl of ammonium bicarbonate pH 8.8 containing 0.15 µg 
of MS grade trypsin (Trypsin Gold, Promega) and were incubated for 16 h at at 37 °C. The resulting proteolytic 
derivatized peptides were detected by MALDI-TOF-MS. A tryptic peptide of NvCI containing three derivatized 
cysteines was sequenced by MALDI-TOF-MS2 to determine which cysteines were initially free (derivatized with 
the first alkylating reagent) or disulfide-bridged (derivatized with the second alkylating reagent).
The acid-trapped fraction IIab from oxidative folding was purified by RP-HPLC using a 4.6 mm Nova Pack 
C8 cartridge (Waters) and a linear gradient from 20–40% of acetonitrile with 0.1% TFA over 50 min at 0.75 ml/
min (See Fig. 6c). The purified heterogeneous fraction was freeze-dried and derivatized by resuspending it in 
90 µl of 0.1 M Tris-HCl (pH 8.4), containing either 0.1 M VP or 0.1 M IAA, and was incubated at RT for 45 min 
in the dark. Then, the derivatized products were separated and purified by RP-HPLC using the same C8 column 
and conditions described before. The purified derivatized fractions were freeze-dried and subjected to reduction 
with 10 mM DTT, followed by a second alternative alkylation step and further subjected to trypsin digestion as 
described above. The resulting derivatized digestion peptides were analyzed by MALDI-TOF-MS and sequenced 
by MS2 as described before.
Stop/Go folding. Acid-trapped intermediates were isolated by RP-HPLC, lyophilized, and allowed to rein-
itiate folding at 0.3 mg/ml in 0.1 M Tris-HCl (pH 8.4) at RT in the absence and in the presence of 0.5 mM GSSG. 
To monitor the stop/go reaction progression, time-course aliquots of the samples were trapped with 2% TFA 
acid and analyzed by RP-HPLC in a C4 column using the same gradient described in oxidative folding. The frac-
tion IIb was purified from the 20 min acid-trapped sample of reductive unfolding with 20 mM TCEP at pH 4.5. 
Fractions I and IIab were purified from the 10 min acid-trapped sample of oxidative folding in the presence of 
0.5 mM GSSG. The stop-go experiments were performed in duplicates at 25 °C.
Disulfide scrambling. The native protein (0.5 mg/ml) was dissolved in 0.1 M Tris-HCl (pH 8.4) containing 
0.25 mM 2-mercaptoethanol and increasing concentrations of denaturants: urea (0–8 M), GdnHCl (0–8 M) or 
GdnSCN (0–5 M). The samples were incubated for 20 h at RT to reach equilibrium and then quenched with 2% 
TFA acid and analyzed by RP-HPLC, as detailed in oxidative folding. The disulfide scrambling experiments were 
performed in duplicates at 25 °C.
Circular Dichroism, Fluorescence and NMR spectroscopy. For oxidative folding, fully reduced/
unfolded NvCI was prepared as described before, allowed to air oxidize for 16 hours and the changes in the sec-
ondary and tertiary structure were monitored by far UV-circular dicroism (CD) and tryptophan fluorescence 
spectroscopy, respectively. The sample for CD spectroscopy was prepared by dissolving the protein to a final 
concentration of 0.1 mg/ml in 20 mM Tris-HCl (pH 8.4). CD spectra were collected at 20 min intervals in a spec-
tropolarimeter (Jasco J-710) at 25 °C using a cell of 1-mm path length. Samples for fluorescence spectroscopy 
were measured in the same buffer on a fluorescence spectrophotometer (Jasco FP-8500) at a final protein con-
centration of 0.05 mg/ml at 25 °C. The spectra were measured every 20 min in the 310–450 nm interval using a 
294-nm excitation wavelength (5 nm excitation and emission slits, 0.1 s averaging time).
For reductive unfolding, native NvCI samples were prepared at 0.03 mg/ml in 50 mM Tris-HCl (pH 8.4) or 
100 mM sodium acetate (pH 4.5). After measuring the native protein spectrum, the reducing agent was added, 
without diluting the samples, to a final concentration of 1.0 mM and 20 mM for DTT (pH 8.4) or 20 mM for TCEP 
(pH 4.5). Tryptophan emission spectra were measured at various time points in the same conditions described 
for oxidative folding.
One-dimensional 1H nuclear magnetic resonance (NMR) spectra were acquired at 25 °C on an Avance 
600-MHz NMR spectrometer (Bruker). Samples coming from the RP-HPLC purified intermediate IIb of reduc-
tive unfolding (obtained by reduction with 20 mM TCEP at pH 4.5) and native NvCI were prepared by dissolving 
the lyophilized purified proteins to a final concentration of 1.5 mg/ml in H2O/D2O (9:1 ratio, v/v) at pH 2.0.
MALDI-TOF analyses. MALDI-TOF mass spectra were recorded on an UltrafleXtreme mass spectrom-
eter (Bruker Daltonics) and the samples were spotted onto a MALDI-TOF-MS ground steel plate using the 
dried-droplet method. For peptide analyses the samples were mixed with α-cyano-4-hydroxycinnamic acid 
(hcca) and acquired in the positive ion reflectron mode, with ion acceleration set to 25 kV. All mass spectra 
were externally calibrated using a standard peptide mixture (Bruker Daltonics). For protein analyses the samples 
were mixed with sinapic acid and acquired in the positive ion lineal mode, with ion acceleration set to 25 kV. All 
mass spectra were externally calibrated using a standard protein mixture ranging from 4 kDa to 20 kDa (Bruker 
Daltonics). For tandem MS analyses samples were mixed with hcca and acquired in positive LIFT reflectron mode 
with ion acceleration set to 7.5 kV and LIFT voltage set to 19 kV.
Determination of MCPs inhibitory activities of native NvCI and des(15–51) intermediate. 
Bovine carboxypeptidase A (bCPA1) and porcine carboxypeptidase B (pCPB1) were purchased from Sigma. 
Human carboxypeptidase A1 (hCPA1) and human carboxypeptidase B1 (hCPB1) were produced by recombinant 
expression as previously described35, 58.
The inhibitory activity of native NvCI and des(15–51) folding intermediate were assayed by measuring the 
inhibition of the hydrolysis of the chromogenic substrate N-(4-methoxyphenylazoformyl)-Phe-OH by CPAs and 
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N-(4-methoxyphenylazoformyl)-Arg-OH (Bachem) by CPBs at 355 nm. The inhibition assays were performed in 
20 mM Tris-HCl (pH 7.5), 1% v/v DMSO, 0.05% w/v Brij-35 with 0.5 M NaCl for CPAs or 0.1 M NaCl for CPBs. 
The assay was performed at 37 °C in a 96-well microplate format with a final volume of 250 µl adding 20 µl of the 
substrate to start the reaction, at a final concentration of 0.1 mM. The reactions were followed at 30 sec interval for 
15 min and measured in terms of initial velocities in a multiplate reader Wallac 1420 VICTOR2 (PerkinElmer). 
The enzyme concentrations were kept constant (7.5 nM for hCPA1 and 6.0 nM for bCPA1, hCPB1 and pCPB1) 
and increasing amounts of the inhibitors were added in each case. Inhibition constants (Ki) were determined 
according to the method described for tight-binding inhibitors59. The best-fit value of (Ki) was performed by 
adjusting the experimental values to the Morrison equation60 using the program GraphPad Prism 5 (GraphPad 
Software, Inc.) at p < 0.05. Data are means (n = 3) ± S.D. The concentration of the purified solutions of native 
NvCI and des(15–51) were determined from the absorbance at 280 nm using a molar extinction coefficient of 
8855 M−1 cm−1.
References
 1. Dill, K. A. & Chan, H. S. From Levinthal to pathways to funnels. Nature structural biology 4, 10–19 (1997).
 2. Bryngelson, J. D., Onuchic, J. N., Socci, N. D. & Wolynes, P. G. Funnels, pathways, and the energy landscape of protein folding: a 
synthesis. Proteins 21, 167–195 (1995).
 3. Creighton, T. E. The protein folding problem. Science 240(267), 344 (1988).
 4. Gruebele, M. The fast protein folding problem. Annu. Rev. Phys. Chem. 50, 485–516 (1999).
 5. Fetrow, J. S., Giammona, A., Kolinski, A. & Skolnick, J. The protein folding problem: a biophysical enigma. Curr. Pharm. Biotechnol. 
3, 329–347 (2002).
 6. Daggett, V. & Fersht, A. The present view of the mechanism of protein folding. Nat. Rev. Mol. Cell Biol. 4, 497–502 (2003).
 7. Baldwin, R. L. The nature of protein folding pathways: the classical versus the new view. J. Biomol. NMR 5, 103–109 (1995).
 8. Dobson, C. M. & Evans, P. A. Protein structure. Trapping folding intermediates. Nature 335, 666–667 (1988).
 9. Weissman, J. S. All roads lead to Rome? The multiple pathways of protein folding. Chem. Biol. 2, 255–260 (1995).
 10. Weissman, J. S. & Kim, P. S. Reexamination of the folding of BPTI: predominance of native intermediates. Science 253, 1386–1393 
(1991).
 11. Wedemeyer, W. J., Welker, E., Narayan, M. & Scheraga, H. A. Disulfide bonds and protein folding. Biochemistry 39, 4207–4216 
(2000).
 12. Chang, J. Y., Ventura, S. Folding of Disulfide Proteins. Vol. 14 (Springer Science, 2011).
 13. Creighton, T. E. Disulfide bonds as probes of protein folding pathways. Methods Enzymol 131, 83–106 (1986).
 14. Anfinsen, C. B. Principles that govern the folding of protein chains. Science 181, 223–230 (1973).
 15. Creighton, T. E. Protein folding coupled to disulphide bond formation. Biol Chem 378, 731–744 (1997).
 16. Welker, E., Wedemeyer, W. J., Narayan, M. & Scheraga, H. A. Coupling of conformational folding and disulfide-bond reactions in 
oxidative folding of proteins. Biochemistry 40, 9059–9064 (2001).
 17. Narayan, M., Welker, E., Wedemeyer, W. J. & Scheraga, H. A. Oxidative folding of proteins. Acc Chem Res 33, 805–812 (2000).
 18. Wedemeyer, W. J., Welker, E., Narayan, M. & Scheraga, H. A. Disulfide bonds and protein folding. Biochemistry 39, 7032 (2000).
 19. Fass, D. Disulfide bonding in protein biophysics. Annual review of biophysics 41, 63–79 (2012).
 20. Creighton, T. E. Conformational restrictions on the pathway of folding and unfolding of the pancreatic trypsin inhibitor. J Mol Biol 
113, 275–293 (1977).
 21. Chang, J. & Ballatore, A. The structure of denatured bovine pancreatic trypsin inhibitor (BPTI). FEBS Lett 473, 183–187 (2000).
 22. Arolas, J. L., Aviles, F. X., Chang, J. Y. & Ventura, S. Folding of small disulfide-rich proteins: clarifying the puzzle. Trends Biochem Sci 
31, 292–301 (2006).
 23. Mamathambika, B. S. & Bardwell, J. C. Disulfide-linked protein folding pathways. Annu Rev Cell Dev Biol 24, 211–235 (2008).
 24. Creighton, T. E. The disulfide folding pathway of BPTI. Science 256, 111–114 (1992).
 25. Chatrenet, B. & Chang, J. Y. The folding of hirudin adopts a mechanism of trial and error. J. Biol. Chem. 267, 3038–3043 (1992).
 26. Arolas, J. L. & Ventura, S. Protease inhibitors as models for the study of oxidative folding. Antioxid Redox Signal 14, 97–112 (2010).
 27. Arolas, J. L., Vendrell, J., Aviles, F. X. & Fricker, L. D. Metallocarboxypeptidases: emerging drug targets in biomedicine. Curr Pharm 
Des 13, 349–366 (2007).
 28. Fernandez, D., Pallares, I., Covaleda, G., Aviles, F. X. & Vendrell, J. Metallocarboxypeptidases and their inhibitors: recent 
developments in biomedically relevant protein and organic ligands. Curr Med Chem 20, 1595–1608 (2013).
 29. Covaleda, G., del Rivero, M. A., Chavez, M. A. & Aviles, F. X. & Reverter, D. Crystal structure of novel metallocarboxypeptidase 
inhibitor from marine mollusk Nerita versicolor in complex with human carboxypeptidase A4. J Biol Chem 287, 9250–9258 (2012).
 30. Hass, G. M. et al. The amino acid sequence of a carboxypeptidase inhibitor from potatoes. Biochemistry 14, 1334–1342 (1975).
 31. Reverter, D. et al. A carboxypeptidase inhibitor from the medical leech Hirudo medicinalis. Isolation, sequence analysis, cDNA 
cloning, recombinant expression, and characterization. J Biol Chem 273, 32927–32933 (1998).
 32. Arolas, J. L. et al. A carboxypeptidase inhibitor from the tick Rhipicephalus bursa: isolation, cDNA cloning, recombinant expression, 
and characterization. J Biol Chem 280, 3441–3448 (2005).
 33. Homandberg, G. A., Litwiller, R. D. & Peanasky, R. J. Carboxypeptidase inhibitors from Ascaris suum: the primary structure. Arch 
Biochem Biophys 270, 153–161 (1989).
 34. Sanglas, L., Aviles, F. X., Huber, R., Gomis-Ruth, F. X. & Arolas, J. L. Mammalian metallopeptidase inhibition at the defense barrier 
of Ascaris parasite. Proc Natl Acad Sci USA 106, 1743–1747 (2009).
 35. Arolas, J. L. et al. The three-dimensional structures of tick carboxypeptidase inhibitor in complex with A/B carboxypeptidases reveal 
a novel double-headed binding mode. J Mol Biol 350, 489–498 (2005).
 36. Scalley, M. L. & Baker, D. Protein folding kinetics exhibit an Arrhenius temperature dependence when corrected for the temperature 
dependence of protein stability. Proc Natl Acad Sci USA 94, 10636–10640 (1997).
 37. Chang, J. Y. A two-stage mechanism for the reductive unfolding of disulfide-containing proteins. J Biol Chem 272, 69–75 (1997).
 38. Chang, J. Y. Denatured states of tick anticoagulant peptide. Compositional analysis of unfolded scrambled isomers. J Biol Chem 274, 
123–128 (1999).
 39. Chang, J. Y. & Li, L. The structure of denatured alpha-lactalbumin elucidated by the technique of disulfide scrambling: fractionation 
of conformational isomers of alpha-lactalbumin. J Biol Chem 276, 9705–9712 (2001).
 40. Chang, J. Y., Li, L., Canals, F. & Aviles, F. X. The unfolding pathway and conformational stability of potato carboxypeptidase 
inhibitor. J Biol Chem 275, 14205–14211 (2000).
 41. Scheraga, H. A., Konishi, Y. & Ooi, T. Multiple pathways for regenerating ribonuclease A. Adv. Biophys. 18, 21–41 (1984).
 42. Kim, P. S. & Baldwin, R. L. Specific intermediates in the folding reactions of small proteins and the mechanism of protein folding. 
Annu Rev Biochem 51, 459–489 (1982).
 43. Kim, P. S. & Baldwin, R. L. Intermediates in the folding reactions of small proteins. Annu Rev Biochem 59, 631–660 (1990).
 44. Dill, K. A. Dominant forces in protein folding. Biochemistry 29, 7133–7155 (1990).
www.nature.com/scientificreports/
1 6Scientific RepoRts | 7: 5457  | DOI:10.1038/s41598-017-05657-7
 45. Chang, J. Y. Diverse pathways of oxidative folding of disulfide proteins: underlying causes and folding models. Biochemistry 50, 
3414–3431 (2011).
 46. Arolas, J. L., Aviles, F. X., Chang, J. Y. & Ventura, S. Folding of small disulfide-rich proteins: clarifying the puzzle. Trends Biochem. 
Sci. 31, 292–301 (2006).
 47. Chang, J. Y., Canals, F., Schindler, P., Querol, E. & Aviles, F. X. The disulfide folding pathway of potato carboxypeptidase inhibitor. J 
Biol Chem 269, 22087–22094 (1994).
 48. Safavi-Hemami, H. et al. Modulation of conotoxin structure and function is achieved through a multienzyme complex in the venom 
glands of cone snails. J Biol Chem 287, 34288–34303 (2012).
 49. Sen, T. Z., Jernigan, R. L., Garnier, J. & Kloczkowski, A. GOR V server for protein secondary structure prediction. Bioinformatics 21, 
2787–2788, doi:10.1093/bioinformatics/bti408 (2005).
 50. McGuffin, L. J., Bryson, K. & Jones, D. T. The PSIPRED protein structure prediction server. Bioinformatics 16, 404–405 (2000).
 51. Schymkowitz, J. et al. The FoldX web server: an online force field. Nucleic Acids Res 33, W382–388 (2005).
 52. Jamroz, M., Kolinski, A. & Kmiecik, S. CABS-flex: Server for fast simulation of protein structure fluctuations. Nucleic Acids Res 41, 
W427–431 (2013).
 53. Darby, N. & Creighton, T. E. Disulfide bonds in protein folding and stability. Methods Mol Biol 40, 219–252 (1995).
 54. Bulychev, A. & Chang, J. Y. Unfolding of hirudin characterized by the composition of denatured scrambled isomers. J Protein Chem 
18, 771–778 (1999).
 55. Matagne, A. & Dobson, C. M. The folding process of hen lysozyme: a perspective from the ‘new view’. Cell Mol Life Sci 54, 363–371 
(1998).
 56. Kahn, T. B., Fernandez, J. M. & Perez-Jimenez, R. Monitoring Oxidative Folding of a Single Protein Catalyzed by the Disulfide 
Oxidoreductase DsbA. J Biol Chem 290, 14518–14527 (2015).
 57. Kosuri, P. et al. Protein folding drives disulfide formation. Cell 151, 794–806 (2012).
 58. Pallares, I. et al. Direct interaction between a human digestive protease and the mucoadhesive poly(acrylic acid). Acta Crystallogr D 
Biol Crystallogr D64, 784–791 (2008).
 59. Bieth, J. G. Theoretical and practical aspects of proteinase inhibition kinetics. Methods Enzymol 248, 59–84 (1995).
 60. Morrison, J. F. The slow-binding and slow, tight-binding inhibition of enzyme-catalysed reactions. TIBS 7, 102–105 (1982).
Acknowledgements
S.V. has been granted an ICREA ACADEMIA award. SV and FXA are supported by the Spanish Ministry of 
Economy and Competitiveness (MINECO), through projects BFU2013-44763-P and BIO2013-44973-R, 
respectively. SAE and SAT are CONICET (Consejo Nacional de Investigaciones Científicas y Técnicas) Career 
Investigators. Mass spectrometry analyses were performed in SePBioES, the proteomics facility from UAB.
Author Contributions
Conceived and supervised: S.V. and F.X.A. Performed the experiments: S.A.E. and G.C. Design, analysis and 
interpretation of experiments: S.A.E., S.A.T., S.B. and S.V. Wrote the paper: S.A.E. and S.V.
Additional Information
Supplementary information accompanies this paper at doi:10.1038/s41598-017-05657-7
Competing Interests: The authors declare that they have no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2017
